432 filings
Page 5 of 22
424B3
isubp 4qxrba9upd
12 Feb 21
Prospectus supplement
9:43pm
EFFECT
jk92e kalj3jb
12 Feb 21
Notice of effectiveness
12:00am
424B5
3nzf2x
10 Feb 21
Prospectus supplement for primary offering
9:56pm
CORRESP
mj1ykvo7i54c 36xg
10 Feb 21
Correspondence with SEC
12:00am
EFFECT
aopsait
9 Feb 21
Notice of effectiveness
12:15am
8-K
re3lai
8 Feb 21
Entry into a Material Definitive Agreement
5:22pm
425
i0ma8dvl q5
8 Feb 21
Business combination disclosure
5:20pm
424B3
czpfyeoz0 6bo5wlvq0
8 Feb 21
Prospectus supplement
4:55pm
S-4/A
5t5q0g9hercaq1 x8r
8 Feb 21
Registration of securities issued in business combination transactions (amended)
10:46am
CORRESP
2l4p whuurwirzuyu5
5 Feb 21
Correspondence with SEC
12:00am
UPLOAD
163k d3f9e
5 Feb 21
Letter from SEC
12:00am
D
gl19cgas8 75ia
3 Feb 21
$10M in equity / options / securities to be acquired, sold $10M, 6 investors
9:03am
8-K
bzxie 1qpyr
1 Feb 21
Cancer Genetics Announces $10.0 Million Private Placement Priced At-the-Market
5:24pm
8-K
3iqmw
28 Jan 21
Other Events
3:42pm
425
nisqw3cosgnu17tm4t
28 Jan 21
Business combination disclosure
3:40pm
425
ogd3o 7mifubx
8 Jan 21
Business combination disclosure
4:30pm
8-K
yse2s
8 Jan 21
Regulation FD Disclosure
4:30pm
8-K
66b6xw 7irp0p44
7 Jan 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:30am
425
7zkmb47q5c8ykgbu
7 Jan 21
Business combination disclosure
8:30am